
Webinar
Navigating the Path to Clinical Implementation and Future Outlook
- Past
- 13/02/2025 11:00 Europe/Brussels
Discover unique insights from esteemed experts in the field of Targeted Alpha Therapy, from the latest advancements in radiopharmaceutical development, through key clinical trials involving Actinium-225, to the early and upcoming trials with Astatine-211.
This webinar is already ready over. Missed the live webinar or want to rewatch it?
Speakers
Speakers
Prof Dr Frederik GieselChairman of Nuclear Medicine Department, University Hospital Düsseldorf (UKD), Germany & Visiting Professor at the Osaka University, JapanUniversity of Dusseldorf, Germany & Osaka University, Japan
Prof Dr Hugo LevillainHead of R&D Medical Physics Department University Hospital Brussels; Co-director of the Radiophysics and MRI physics laboratory Faculty of Medicine ULB; Director of NuMix Center of Microscopy and Molecular Imaging (CMMI) Gosselies ULBUniversity Hospital Brussels, Belgium- Topics
The New Era of Alpha Emitters in the Translation to Clinical Arena
Accelerate.EU, a European initiative: The INSPIRE Study on Astatine-211 Theranostics for Triple-Negative Breast Cancer

